Brief: Infinity Pharmaceuticals Expects Net Loss For 2020 To Range From $35 Million To $45 Million
30/07/2020 21:59
July 30 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* Q2 LOSS PER SHARE $0.16
* Q2 EARNINGS PER SHARE ESTIMATE $-0.19 -- REFINITIV IBES
DATA
* EXPECTS NET LOSS FOR 2020 TO RANGE FROM $35 MILLION TO $45
MILLION
* INFINITY PHARMA - EXPECTS TO END 2020 WITH A YEAR-END
CASH, CASH
EQUIVALENTS AND AVAILABLE-FOR-SALE SECURITIES BALANCE RANGING
FROM $20 MILLION TO $30 MILLION
* INFINITY PHARMA - EXPECTS EXISTING CASH, CASH EQUIVALENTS
&
AVAILABLE-FOR-SALE SECURITIES, WILL BE ADEQUATE TO SATISFY
CAPITAL NEEDS INTO 2H2021
Source text for Eikon: ID:nBw1z9Gsva
Further company coverage: INFI.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX